Cancer risk reduction

Green tea catechin study retraction becomes the 12th for nutrition researcher

15-Jan-2019 By Will Chu

Journal chief editors cite "unavailability of original data and records, and ambiguous identification of samples and treatments" as to why the publication retracted six papers by a nutritional researcher — his 12th in total.

PROBIOTA 2019 PREVIEW

EC: ‘Prediction & prevention’ on the agenda in future EU microbiome-based projects

15-Jan-2019 By Will Chu

The shift from a ‘diagnose and treat’ mind-set to a ‘predict and prevent’ approach is making rapid gains in the food and nutrition industry as consumers look to innovation to make better dietary and nutritional decisions.

Review reiterates fibre’s prebiotic benefits in warding off stroke and diabetes

11-Jan-2019 By Will Chu

A Lancet review links high intake of fibre and whole grains with a reduced risk of stroke, type 2 diabetes and colorectal cancer in research that highlights missed fibre targets of populations worldwide.

Don't dine with the stars: Worst fad diets of 2018 revealed

07-Jan-2019 By Nikki Cutler

Experts from the British Dietetic Association (BDA) have revealed five of the ‘wildest’ diet fads they’ve come across over the last year to help consumers avoid them in 2019.

Fibre augmentation: Are food labels missing an ‘F’ word?

07-Dec-2018 By Nikki Cutler

Fibre must join the front of pack nutritional guide as populations throughout Europe are in need of “fibre augmentation”, according to a food and nutrition expert.

Non-alcoholic, nutrient-fortified beer created to tackle chemotherapy side effects

03-Aug-2018 By Will Chu

A nutrient-rich, non-alcoholic beer can address the nutrients lost and changes to taste that patients face when undergoing therapy or treatments for cancer, its makers say.

Probiota Asia: World-leading probiotics summit returns to Singapore — calls for abstracts

02-Jul-2018 By Gary Scattergood

NutraIngredients-Asia is delighted to announce that the second Asia edition of the global probiotics and prebiotics summit, Probiota, will be held in Singapore in October.

Tea extracts form nanoparticle starting point in tackling lung cancer

21-May-2018 By Will Chu

Nanoparticles made from tea leaves appear to halt the growth of up to 80% of lung cancer cells, a UK study shows, opening up possibilities for a non-toxic plant-based alternative method of production.

Cell study links iron to certain cancer markers

17-Apr-2018 By Tim Cutcliffe

The increased formation of a known biomarker for colon cancer has been linked to two forms of iron in commonly used supplements, say researchers.

Curcumin trial retraction latest in long line for retired researcher

13-Apr-2018 By Will Chu

Journal chief editors have cited 'inconsistencies in experimental rigour' concerning a curcumin anti-cancer trial, co-authored by a researcher with a history of multiple study retractions.

Better bioavailability: Novel curcumin formulation could overcome absorption issues

06-Apr-2018 By Tim Cutcliffe

The use of a gamma-cyclodextrin formulation in curcumin supplements could provide a significant boost to bioavailability, say researchers who report a 39-fold improvement versus standardised unformulated curcumin.

What is standing in the way of people adopting a healthy plant-based diet? An expert explains

03-Apr-2018 By Tim Cutcliffe

The multiple health benefits of adopting a plant-based diet are currently an area of focus. However, a number of obstacles exist which may deter people from making the switch.

Plant-based diets: Are they nutritionally complete?

28-Mar-2018 By Tim Cutcliffe

Switching to a wholly plant-based diet has raised questions about nutrient deficiencies in vegans. But have these concerns been overstated?

Genetic risk? Chondroitin sulphate supplements linked to skin cancer growth

20-Mar-2018 By Tim Cutcliffe

Chondroitin sulphate could accelerate cell growth in certain types of melanoma in certain genetic groups, a new study has suggested.

Is placebo ethical in vitamin D supplementation trials?

19-Mar-2018 By Tim Cutcliffe

Placebo-controlled trials that limit supplementation potentially place people at risk of undue harm, warn rearchers.